Overexpression of PIK3CA impacts global survival of patients with HER2 subtype breast carcinoma.

CONCLUSIONS: The PIK3CA expression showed a protective effect in relation to the OS of patients with HER2-positive breast cancer. PMID: 33455095 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/33455095?dopt=Abstract

Source: Journal of B.U.ON. - January 20, 2021 Category: Cancer & Oncology Tags: J BUON Source Type: research